Oxford Technology 2 (OT3) Venture Capital Trust PLC
Sell:5.00p
Buy:9.00p
0
Change:
No change
No change
Market closed |
Prices as at close on 21 February 2025
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- This stock can be held in a
Sell:5.00p
Buy:9.00p
Change:
No change
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 21 February 2025
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:5.00p
Buy:9.00p
Change:
No change
No change
Market closed |
Prices as at close on 21 February 2025
Prices delayed by at least 15 minutes
|
Switch to live prices
|
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
The Company will target unquoted companies which meet the relevant criteria under the VCT Rules and which it believes will achieve the objective of producing attractive income and capital return for Shareholders.
| Security | Weight |
|---|---|
| Arecor (Bid Price 185P) | 39.80% |
| Select Stl Management | 29.50% |
| Scancell (Bid Price 9.5P) | 14.54% |
| Imm Bio | 4.30% |
| Select Technology Stl Mgt. | 4.28% |
| Diamond Hard Surfaces | 2.47% |
| Biocote | 1.63% |
| Getmapping | 0.89% |
| Novacta | 0.80% |
| Invro | 0.14% |
Top 10 sectors currently unavailable.
| Country | Weight |
|---|---|
| United Kingdom | 0.89% |
Fee Structure
The management fee is 1% of NAV p.a. The performance fee becomes payable if a certain cash return threshold to shareholders is exceeded. The excess is then subject to a 20% carry that is distributed to Oxford Technology Management, past Directors and current Directors the remaining 80% is returned to shareholders.
Dividend Policy
The Directors are not recommending the payment of a dividend at this time.
ASSET SPLIT
Trust Manager
Not currently available for this investment trust.
Manager Bio
Not currently available for this investment trust.
Board Of Directors
Robin GoodfellowChairman, David Livesley, Richard Roth, Alex Starling
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.